Generate What You Can Make: Achieving in-house synthesizability with readily available resources in de novo drug design
Molecules generated by Computer-Aided Drug Design often lack synthesizability to be valuable because Computer-Aided Synthesis Planning (CASP) and CASP-based approximated synthesizability scores have rarely been used as generation objectives, despite facilitating the in-silico generation of synthesizable molecules. Published scores approximate a general notion of CASP-based synthesizability with nearly unlimited building block resources. However, this approach is disconnected from the reality of small laboratory drug design, where building block resources are limited, making a notion of in-house synthesizability that uses already available resources highly desirable.
In this work, we show a successful de novo drug design workflow generating active and in-house synthesizable ligands of monoglyceride lipase (MGLL). We demonstrate the successful transfer of CASP from 17.4 million commercial building blocks to a small laboratory setting of roughly 6,000 building blocks with only a decrease of –12% in CASP success. Moreover, we present a rapidly retrainable in-house synthesizability score, successfully capturing our in-house synthesizability without relying on external building block resources. We show that including our in-house synthesizability score in a multi-objective de novo drug design workflow, alongside a simple QSAR model, provides thousands of potentially active and easily in-house synthesizable molecules. Further, we highlight differences between general and in-house synthesizability scores and demonstrate potential problems with the out-of-distribution predictive performance of synthesizability scores on generated molecules. Finally, we experimentally evaluate the synthesis and biochemical activity of three de novo candidates using their CASP-suggested synthesis routes using only in-house building blocks. We find one candidate with evident activity, suggesting potential new ligand ideas for MGLL inhibitors while showcasing the usefulness of our in-house synthesizability score.
# Example installation command
make create_conda_env
conda activate led3_score
make install_packagesFind the jupyter notebooks/scripts in the respective folders.
The models and data associated with this paper will be made available upon its publication or upon request.
If you use our work in your research, please cite:
Will be updated...
}